GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Acquires Intelligent Ultrasound's Clinical AI Business
GEHC acquires clinical AI business to aid its ultrasound portfolio with AI-driven image analysis tools.
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
US FDA approves GE HealthCare's diagnostic drug for heart disease
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
GE HealthCare: The Image Of More Upside Is Very Real
GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June, outperforming the S&P 500's 2.9% rise. Despite some revenue declines in key segments, the PDx segment's 12.5% growth and overall profitability improvements are encouraging. Management's revised guidance suggests a positive outlook, with expected EPS growth and improved EBIT margins, indicating strong future potential.
This GE HealthCare Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
GE HealthCare Stock Is Rising. Why One Analyst Says Buy.
BTIG analyst Ryan Zimmerman upgraded GE HealthCare stock to Buy from Hold. His new price target is $100, implying about 15% upside.
GE HealthCare's stock pulls back after former parent sells off half its stake
GE HealthCare's stock is ending a good week on a bad note on Friday, after its former parent, now known as GE Aerospace, took advantage of the recent rally to sell off about one half of its remaining stake.
GE Healthcare (GEHC) stock is a bargain – Morningstar
GE Healthcare (NASDAQ: GEHC) stock price has bounced back in the past few months, helped by the overall recovery of American equities and the view that it is a bargain company. It rose to a high of $88.51 on Thursday, its highest level since April 29th.
